CERo Therapeutics Holdings, Inc. Share Price & Technical Analysis
CERO · $0.02 (0.00%)
Healthcare / Biotechnology
$0.02
0.00%
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
-200% return in 2026, -176% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -100% | -100% | – | – | – | – | – | – | – | – | – | – | -200% |
| 25 | -65% | -19% | -56% | 30% | -49% | 14% | -16% | -3% | -30% | -98% | 0% | 0% | -292% |
| 24 | 0% | -73% | -9% | -52% | -35% | -69% | -46% | -18% | -24% | -8% | 157% | -67% | -242% |
| 23 | 2% | 0% | 1% | 3% | -2% | 1% | -1% | 0% | 0% | 0% | 0% | 1% | 6% |
| 22 | 0% | 0% | 1% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | 1% | 0% | 4% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Exhausted
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.13M
P/E ratio
—
52W high
$26.99
52W low
$0.02
Volume
65,600
Beta
0.24
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
Unitedhealth Group Inc
₹6,600
Frequently asked questions
- What is CERo Therapeutics Holdings, Inc. share price today?
- CERo Therapeutics Holdings, Inc. (CERO) last traded around $0.02 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CERO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CERO. Download the app for real-time alerts.
- How can I analyze CERo Therapeutics Holdings, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.